Suppr超能文献

人肝细胞癌和肝内胆管癌的蛋白质组景观。

Proteome Landscapes of Human Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.

机构信息

Center for ProtTalks, Westlake Laboratory of Life Sciences and Biomedicine, Key Laboratory of Structural Biology of Zhejiang Province, School of Life Sciences, Westlake University, Hangzhou, Zhejiang, China; Institute of Basic Medical Sciences, Westlake Institute for Advanced Study, Hangzhou, Zhejiang, China.

Center for Stem Cell Research and Application, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China; Key laboratory of Biological Targeted Therapy, The Ministry of Education, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.

出版信息

Mol Cell Proteomics. 2023 Aug;22(8):100604. doi: 10.1016/j.mcpro.2023.100604. Epub 2023 Jun 22.

Abstract

Liver cancer is among the top leading causes of cancer mortality worldwide. Particularly, hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (CCA) have been extensively investigated from the aspect of tumor biology. However, a comprehensive and systematic understanding of the molecular characteristics of HCC and CCA remains absent. Here, we characterized the proteome landscapes of HCC and CCA using the data-independent acquisition (DIA) mass spectrometry (MS) method. By comparing the quantitative proteomes of HCC and CCA, we found several differences between the two cancer types. In particular, we found an abnormal lipid metabolism in HCC and activated extracellular matrix-related pathways in CCA. We next developed a three-protein classifier to distinguish CCA from HCC, achieving an area under the curve (AUC) of 0.92, and an accuracy of 90% in an independent validation cohort of 51 patients. The distinct molecular characteristics of HCC and CCA presented in this study provide new insights into the tumor biology of these two major important primary liver cancers. Our findings may help develop more efficient diagnostic approaches and new targeted drug treatments.

摘要

肝癌是全球癌症死亡的主要原因之一。特别是肝细胞癌(HCC)和肝内胆管癌(CCA)在肿瘤生物学方面已经得到了广泛的研究。然而,对 HCC 和 CCA 的分子特征仍缺乏全面而系统的了解。在这里,我们使用数据非依赖采集(DIA)质谱(MS)方法对 HCC 和 CCA 的蛋白质组图谱进行了表征。通过比较 HCC 和 CCA 的定量蛋白质组,我们发现了这两种癌症类型之间的一些差异。特别是,我们在 HCC 中发现了异常的脂质代谢,在 CCA 中发现了激活的细胞外基质相关途径。接下来,我们开发了一个三蛋白分类器来区分 CCA 和 HCC,在 51 名患者的独立验证队列中,曲线下面积(AUC)为 0.92,准确率为 90%。本研究中呈现的 HCC 和 CCA 的不同分子特征为这两种主要原发性肝癌的肿瘤生物学提供了新的见解。我们的发现可能有助于开发更有效的诊断方法和新的靶向药物治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93cf/10413158/3cd6d925d0a4/ga1.jpg

相似文献

1
Proteome Landscapes of Human Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.
Mol Cell Proteomics. 2023 Aug;22(8):100604. doi: 10.1016/j.mcpro.2023.100604. Epub 2023 Jun 22.
2
Plasma proteome atlas for differentiating tumor stage and post-surgical prognosis of hepatocellular carcinoma and cholangiocarcinoma.
PLoS One. 2020 Aug 26;15(8):e0238251. doi: 10.1371/journal.pone.0238251. eCollection 2020.
3
Annexin A1: A new immunohistological marker of cholangiocarcinoma.
World J Gastroenterol. 2013 Apr 28;19(16):2456-65. doi: 10.3748/wjg.v19.i16.2456.
6
Differential Expression of Sonic Hedgehog Protein in Human Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.
Pathol Oncol Res. 2015 Sep;21(4):901-8. doi: 10.1007/s12253-015-9918-7. Epub 2015 Mar 5.
8
Mixed hepatocellular cholangiocarcinoma tumors: Cholangiolocellular carcinoma is a distinct molecular entity.
J Hepatol. 2017 May;66(5):952-961. doi: 10.1016/j.jhep.2017.01.010. Epub 2017 Jan 23.
10
Deep learning-based phenotyping reclassifies combined hepatocellular-cholangiocarcinoma.
Nat Commun. 2023 Dec 14;14(1):8290. doi: 10.1038/s41467-023-43749-3.

引用本文的文献

1
Plasma proteomic signature for preoperative prediction of microvascular invasion in HCC.
JHEP Rep. 2025 Jun 10;7(9):101481. doi: 10.1016/j.jhepr.2025.101481. eCollection 2025 Sep.
5
HKDC1 promotes liver cancer stemness under hypoxia through stabilizing β-catenin.
Hepatology. 2025 Jun 1;81(6):1685-1699. doi: 10.1097/HEP.0000000000001085. Epub 2024 Sep 6.
6
Unveil Intrahepatic Cholangiocarcinoma Heterogeneity through the Lens of Omics and Multi-Omics Approaches.
Cancers (Basel). 2024 Aug 20;16(16):2889. doi: 10.3390/cancers16162889.
7
Majorbio Cloud 2024: Update single-cell and multiomics workflows.
Imeta. 2024 Jun 25;3(4):e217. doi: 10.1002/imt2.217. eCollection 2024 Aug.
8
Overexpression of TBX3 suppresses tumorigenesis in experimental and human cholangiocarcinoma.
Cell Death Dis. 2024 Jun 22;15(6):441. doi: 10.1038/s41419-024-06839-8.
9
High-throughput proteomics-guided biomarker discovery of hepatocellular carcinoma.
Biomed J. 2025 Feb;48(1):100752. doi: 10.1016/j.bj.2024.100752. Epub 2024 Jun 18.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验